Homepage

				[{"id":12762,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/lallianse\/","name":"lallianse","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Lallianse-1.png","alt":""},"title":"LallianSe","author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 5, 2024","dateGMT":"2024-12-05 15:37:38","modifiedDate":"2024-12-09 22:25:14","modifiedDateGMT":"2024-12-09 21:25:14","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/sponsors-partners\/\" rel=\"category tag\">Sponsors & Partners<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/sponsors-partners\/\" rel=\"category tag\">Sponsors & Partners<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":51},"status":"publish","excerpt":"LallianSe\u00a0is an innovation integrator and a venture builder that has supported more than 100 companies since its inception, almost a decade ago. Its\u00a0mission\u00a0: to build the enabling environment to successfully develop healthcare innovations through the articulation of equity stories."},{"id":12729,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/icosa-2\/","name":"icosa-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Cooley.png","alt":""},"title":"Cooley LLP","author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 4, 2024","dateGMT":"2024-12-04 15:47:03","modifiedDate":"2024-12-04 16:47:24","modifiedDateGMT":"2024-12-04 15:47:24","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/sponsors-partners\/\" rel=\"category tag\">Sponsors & Partners<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/sponsors-partners\/\" rel=\"category tag\">Sponsors & Partners<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":26},"status":"publish","excerpt":"Cooley LLP is an American international law firm, headquartered in Palo Alto, California, with offices worldwide. The firm's practice areas include corporate, litigation, intellectual property, fund formation, public markets, employment, life sciences, clean technology, real estate, financial services, retail, regulatory and Energy."},{"id":12715,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/icosa\/","name":"icosa","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Icosa.png","alt":""},"title":"ICOSA","author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 4, 2024","dateGMT":"2024-12-04 15:33:10","modifiedDate":"2024-12-04 16:47:37","modifiedDateGMT":"2024-12-04 15:47:37","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/sponsors-partners\/\" rel=\"category tag\">Sponsors & Partners<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/sponsors-partners\/\" rel=\"category tag\">Sponsors & Partners<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":56},"status":"publish","excerpt":"ICOSA is an intellectual property firm dedicated to the health sector and specialized in Life Sciences and Medtech.It operates at all the stages of the protection of the Intellectual Property, by filing patents and trademarks, by elaborating strategies of Industrial Property, by issuing Legal Opinions on the patentability or the freedom to operate and by financially evaluating the value of portfolios of Intellectual Property assets."},{"id":12696,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/orcom-us\/","name":"orcom-us","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Orcom.png","alt":""},"title":"Orcom US","author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 3, 2024","dateGMT":"2024-12-03 22:19:49","modifiedDate":"2024-12-20 22:22:41","modifiedDateGMT":"2024-12-20 21:22:41","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/sponsors-partners\/\" rel=\"category tag\">Sponsors & Partners<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/sponsors-partners\/\" rel=\"category tag\">Sponsors & Partners<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":36},"status":"publish","excerpt":"ORCOM US is a US based accounting and tax services firm with American Certified Public Accountants (CPAs), ACCA and French diplomes \u201cExperts-comptables\u201d (French CPA licensees)."},{"id":12650,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/klava-2\/","name":"klava-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/12\/Klava.png","alt":""},"title":"Klava","author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 3, 2024","dateGMT":"2024-12-03 20:21:19","modifiedDate":"2024-12-03 23:02:21","modifiedDateGMT":"2024-12-03 22:02:21","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":48},"status":"publish","excerpt":"The KLAVA laboratory develops digital medical devices (DTx), downloadable onto smartphones. The solutions are sold by prescription in pharmacies. They are recommended to assist in the process of addictions, notably sugar and tobacco."},{"id":12648,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/dolinnov\/","name":"dolinnov","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/12\/Dolinnov.png","alt":""},"title":"Dolinnov","author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 3, 2024","dateGMT":"2024-12-03 20:09:25","modifiedDate":"2024-12-03 23:02:00","modifiedDateGMT":"2024-12-03 22:02:00","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":40},"status":"publish","excerpt":"Dolinnov aims to develop an innovative therapeutic approach based on antisense technology to treat chronic pain, particularly neuropathic and inflammatory pain. The company specifically targets a novel therapeutic target within the peripheral nervous system, concentrating on the dorsal root ganglia (DRG)."},{"id":12638,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/novalix\/","name":"novalix","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/12\/Novalix-1.png","alt":""},"title":"Novalix","author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 3, 2024","dateGMT":"2024-12-03 19:50:53","modifiedDate":"2024-12-13 19:55:24","modifiedDateGMT":"2024-12-13 18:55:24","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/cro-cdmo\/\" rel=\"category tag\">CRO & CDMO<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/cro-cdmo\/\" rel=\"category tag\">CRO & CDMO<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":11},"status":"publish","excerpt":"Novalix is a premier contract research organization, dedicated to improving the critical early stages of drug discovery by combining exceptional scientific talent and exclusive technology with a comprehensive portfolio of world-class chemistry, biophysics and pharmacology capabilities."},{"id":12432,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/pepkon\/","name":"pepkon","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-JPM-2025-19.png","alt":""},"title":"PepKon","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 21, 2024","dateGMT":"2024-11-21 19:26:16","modifiedDate":"2024-11-26 21:29:10","modifiedDateGMT":"2024-11-26 20:29:10","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":58},"status":"publish","excerpt":"PepKon is a French biotech start-up developing first-in-class therapeutic peptides for refractory or incurable cancers. Leveraging ten years of academic research, its lead candidate is a CD47 agonist derived from thrombospondin-1. It acts through a novel, calcium-dependent and selective mechanism of action that kills cancer cells while sparing healthy ones."},{"id":12428,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/inflectis-bioscience\/","name":"inflectis-bioscience","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-JPM-2025-18.png","alt":""},"title":"InFlectis BioScience","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 21, 2024","dateGMT":"2024-11-21 19:07:48","modifiedDate":"2024-12-04 23:31:30","modifiedDateGMT":"2024-12-04 22:31:30","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":59},"status":"publish","excerpt":"InFlectis Bioscience is developing first-in-class therapies for neuromuscular diseases and is currently evaluating in clinic an orally available small molecule, named IFB-088 (icerguastat) that has the potential to extend lives or improve the quality-of-life for people suffering from Amyotrophic Lateral Sclerosis (ongoing phase II clinical trial) and demyelinating diseases like Charcot-Marie-Tooth disease (phase 2 ready package)."},{"id":12331,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/emobot-2\/","name":"emobot-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Emobot.png","alt":""},"title":"EMOBOT","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 19, 2024","dateGMT":"2024-11-19 22:04:22","modifiedDate":"2024-12-06 21:33:29","modifiedDateGMT":"2024-12-06 20:33:29","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":6},"status":"publish","excerpt":"EMOBOT, a French based MedTech startup that develops an continuous Clinical Endpoint as a novel Gold Standard and a Digital Therapeutics for mood disorders."},{"id":12130,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/advanced-biodesign\/","name":"advanced-biodesign","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/ADVANCED-BIODESIGN-1.png","alt":""},"title":"ADVANCED BIODESIGN","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 20:01:31","modifiedDate":"2024-12-05 16:44:16","modifiedDateGMT":"2024-12-05 15:44:16","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":5,"sec":1},"status":"publish","excerpt":"Founded by Ismail Ceylan in 2010, ABD is a groundbreaking biotech company with a strong leadership team"},{"id":12187,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/torskal\/","name":"torskal","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-JPM-2025-16.png","alt":""},"title":"Torskal","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 19:44:54","modifiedDate":"2024-11-27 17:28:14","modifiedDateGMT":"2024-11-27 16:28:14","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":24},"status":"publish","excerpt":"TORSKAL is an international biotech\/medtech company and a pioneer in green nanotechnology. The company designs gold nanoparticles for cancer treatment using green chemistry"}]